William Kim
Biotech Executive Leader | Commercial Strategy & Market Access | Driving Patient Access & Growth
- Role
- Responsible for Early to Late-stage Asset Pricing & Contracting and Value-based Contracting Across Entire Portfolio at Sanofi
- Location
- Franklin Lakes, NJ, US
- LinkedIn followers
- 500 followers
About William Kim
Biotech market access leader with 15+ years of experience driving pricing, payer, and launch strategies across oncology, neuroscience, and specialty therapeutics. Proven track record in scaling products to $1B+ annual sales, optimizing gross-to-net, and leading cross-functional teams that deliver measurable access and growth.Former VP at Eagle Pharmaceuticals and executive leader at Novartis, Celgene, and Sanofi. Currently advising biotech clients on market access, pricing, and commercialization strategy for oncology and rare disease assets.Combines clinical insight (PharmD) and commercial expertise (Wharton MBA) to align payer, provider, and enterprise priorities that advance innovation and patient access.
Experience
Responsible for Early to Late-stage Asset Pricing & Contracting and Value-based Contracting Across Entire Portfolio
Present
Education
The Wharton School
Master of Business Administration (MBA)
Rutgers University
Doctor of Pharmacy (Pharm.D.)
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.